Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Stem cell therapy shows promise for treating skin disorders.

Induced pluripotent stem cells are a major breakthrough in regenerative medicine.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Two rare genetic diseases cause severe rickets in children due to defects in vitamin D metabolism.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Testosterone's effects on COVID-19 are unclear and need more research.

Extracellular vesicles can both worsen and help treat age-related diseases and are useful for early diagnosis.

Microneedles with extracellular vesicles show promise for treating various conditions with targeted delivery.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Microneedle Treatment System is effective for hair growth and skin improvement with no serious side effects, but more research is needed.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Androgen use may increase the risk of stroke, but more research is needed.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.

Microneedles improve drug delivery, patient compliance, and have potential in cancer treatment and skin care.

Xenobiotic-free progenitor cells improve wound healing and blood vessel formation.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

3-Deoxysappanchalcone helps human hair cells grow and stimulates hair growth in mice by affecting certain cell signaling pathways.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Targeting CXCL12 may help treat hair loss caused by androgens.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

New treatments like nanotechnology show promise in improving skin cancer therapy.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.